Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gnosia Achniotou"'
Autor:
Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry.Objectives: The aim of thi
Externí odkaz:
https://doaj.org/article/91efa0738a404ac58954a5cf23bc3c10
Autor:
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso Guerra, Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell, Alan Haycox
Publikováno v:
Frontiers in Public Health, Vol 6 (2018)
Introduction: There is continued unmet medical need for new medicines across countries especially for cancer, immunological diseases, and orphan diseases. However, there are growing challenges with funding new medicines at ever increasing prices alon
Externí odkaz:
https://doaj.org/article/44e09c6a8ab54400ba7f5f970ab42861
Autor:
Vasileios Kourafalos, Eleonora Allocati, Luka Voncina, Brian Godman, Arianit Jakupi, Robert Plisko, Evelien Moorkens, Kateřina Kohoutová, Nataša Grubiša, Gisbert Selke, Anita Viksna, Arnold G. Vulto, Jurij Fürst, Jaana E. Martikainen, Leona Popelková, Ileana Mardare, Patricia Vella Bonanno, Vincent Suttorp, Dorthe Bartels, Sarah Mörtenhuber, Ott Laius, Iris Hoxha, Gustaf Befrits, Isabelle Huys, Dmitry Meshkov, Gnosia Achniotou, Rannveig Einarsdóttir, Øyvind Melien, Juraj Slabý, Ieva Greičiūtė-Kuprijanov, Simon Keuerleber, Einar Magnusson, Corinne Zara, Admir Malaj, Robert Puckett, Silvia Stockinger, Vanda Marković-Peković, Maria Dimitrova, Vera Vlahović Palčevski, Konstantin Tachkov, Tanja Novakovic, Roisin Adams, Roberta Joppi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, 11:591134. Frontiers Media S.A.
Frontiers in Pharmacology
Volume 11
Frontiers in Pharmacology, 11:591134. Frontiers Media S.A.
Frontiers in Pharmacology
Volume 11
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry.Objectives: The aim of thi